These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26335104)

  • 21. Odanacatib: an emerging novel treatment alternative for postmenopausal osteoporosis.
    Schultz TC; Valenzano JP; Verzella JL; Umland EM
    Womens Health (Lond); 2015 Nov; 11(6):805-14. PubMed ID: 26344800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Odanacatib for the treatment of osteoporosis.
    Boggild MK; Gajic-Veljanoski O; McDonald-Blumer H; Ridout R; Tile L; Josse R; Cheung AM
    Expert Opin Pharmacother; 2015; 16(11):1717-26. PubMed ID: 26149759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of odanacatib in the treatment of postmenopausal women with osteoporosis: a meta-analysis.
    Li J; Qiu Q; Jiang S; Sun J; Pavel V; Li Y
    J Orthop Surg Res; 2024 Aug; 19(1):521. PubMed ID: 39210429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased fracture callus mineralization and strength in cathepsin K knockout mice.
    Gentile MA; Soung do Y; Horrell C; Samadfam R; Drissi H; Duong LT
    Bone; 2014 Sep; 66():72-81. PubMed ID: 24928497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of odanacatib on the radius and tibia of postmenopausal women: improvements in bone geometry, microarchitecture, and estimated bone strength.
    Cheung AM; Majumdar S; Brixen K; Chapurlat R; Fuerst T; Engelke K; Dardzinski B; Cabal A; Verbruggen N; Ather S; Rosenberg E; de Papp AE
    J Bone Miner Res; 2014 Aug; 29(8):1786-94. PubMed ID: 24643905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkey.
    Cusick T; Chen CM; Pennypacker BL; Pickarski M; Kimmel DB; Scott BB; Duong LT
    J Bone Miner Res; 2012 Mar; 27(3):524-37. PubMed ID: 22113921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of mouse cathepsin K structural elements that regulate the potency of odanacatib.
    Law S; Andrault PM; Aguda AH; Nguyen NT; Kruglyak N; Brayer GD; Brömme D
    Biochem J; 2017 Feb; 474(5):851-864. PubMed ID: 28049758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Future directions for new medical entities in osteoporosis.
    Ferrari S
    Best Pract Res Clin Endocrinol Metab; 2014 Dec; 28(6):859-70. PubMed ID: 25432357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5-Year Data From the Phase 3 Long-Term Odanacatib Fracture Trial (LOFT) and its Extension.
    Recker R; Dempster D; Langdahl B; Giezek H; Clark S; Ellis G; de Villiers T; Valter I; Zerbini CA; Cohn D; Santora A; Duong LT
    J Bone Miner Res; 2020 Jul; 35(7):1289-1299. PubMed ID: 32119749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis.
    Costa AG; Cusano NE; Silva BC; Cremers S; Bilezikian JP
    Nat Rev Rheumatol; 2011 Jun; 7(8):447-56. PubMed ID: 21670768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Odanacatib in postmenopausal women with low bone mineral density: a review of current clinical evidence.
    Zerbini CA; McClung MR
    Ther Adv Musculoskelet Dis; 2013 Aug; 5(4):199-209. PubMed ID: 23904864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cathepsin K inhibitors increase distal femoral bone mineral density in rapidly growing rabbits.
    Pennypacker BL; Oballa RM; Levesque S; Kimmel DB; Duong LT
    BMC Musculoskelet Disord; 2013 Dec; 14():344. PubMed ID: 24321244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications of osteoblast-osteoclast interactions in the management of osteoporosis by antiresorptive agents denosumab and odanacatib.
    Sims NA; Ng KW
    Curr Osteoporos Rep; 2014 Mar; 12(1):98-106. PubMed ID: 24477416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Odanacatib (MK-0822)].
    Nagase Y; Tanaka S
    Clin Calcium; 2011 Jan; 21(1):59-62. PubMed ID: 21187595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosis.
    Binkley N; Orwoll E; Chapurlat R; Langdahl BL; Scott BB; Giezek H; Santora AC
    Osteoporos Int; 2021 Jan; 32(1):173-184. PubMed ID: 33200257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the cathepsin K inhibitor odanacatib on bone resorption biomarkers in healthy postmenopausal women: two double-blind, randomized, placebo-controlled phase I studies.
    Stoch SA; Zajic S; Stone J; Miller DL; Van Dyck K; Gutierrez MJ; De Decker M; Liu L; Liu Q; Scott BB; Panebianco D; Jin B; Duong LT; Gottesdiener K; Wagner JA
    Clin Pharmacol Ther; 2009 Aug; 86(2):175-82. PubMed ID: 19421185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of the cathepsin K inhibitor ONO-5334 in postmenopausal osteoporosis: the OCEAN study.
    Eastell R; Nagase S; Ohyama M; Small M; Sawyer J; Boonen S; Spector T; Kuwayama T; Deacon S
    J Bone Miner Res; 2011 Jun; 26(6):1303-12. PubMed ID: 21312264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New therapeutics for osteoporosis.
    Ng KW; Martin TJ
    Curr Opin Pharmacol; 2014 Jun; 16():58-63. PubMed ID: 24699340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cathepsin K osteoporosis trials, pycnodysostosis and mouse deficiency models: Commonalities and differences.
    Brömme D; Panwar P; Turan S
    Expert Opin Drug Discov; 2016; 11(5):457-72. PubMed ID: 27001692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Long-Term Odanacatib Treatment on Bone Gene Expression in Ovariectomized Adult Rhesus Monkeys: Differentiation From Alendronate.
    Muise ES; Podtelezhnikov AA; Pickarski M; Loboda A; Tan Y; Hu G; Thomspon JR; Duong le T
    J Bone Miner Res; 2016 Apr; 31(4):839-51. PubMed ID: 26587671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.